Eric R Muir1, Saurav B Chandra2, Bryan H De La Garza2, Chakradhar Velagapudi3, Hanna E Abboud3, Timothy Q Duong4. 1. Research Imaging Institute, University of Texas Health Science Center, San Antonio, Texas, United States 2Departments of Ophthalmology, Radiology, and Physiology, University of Texas Health Science Center, San Antonio, Texas, United States. 2. Research Imaging Institute, University of Texas Health Science Center, San Antonio, Texas, United States. 3. Department of Medicine, University of Texas Health Science Center, San Antonio, Texas, United States. 4. Research Imaging Institute, University of Texas Health Science Center, San Antonio, Texas, United States 2Departments of Ophthalmology, Radiology, and Physiology, University of Texas Health Science Center, San Antonio, Texas, United States 4South Texas Ve.
Abstract
PURPOSE: To employ high-resolution manganese-enhanced MRI (MEMRI) to study abnormal calcium activity in different cell layers in streptozotocin-induced diabetic rat retinas, and to determine whether MEMRI detects changes at earlier time points than previously reported. METHODS: Sprague-Dawley rats were studied 14 days (n = 8) and 30 days (n = 5) after streptozotocin (STZ) or vehicle (n = 7) injection. Manganese-enhanced MRI at 20 × 20 × 700 μm, in which contrast is based on manganese as a calcium analogue and an MRI contrast agent, was obtained in light and dark adaptation of the retina in the same animals in which one eye was covered and the fellow eye was not. The MEMRI activity encoding of the light and dark adaptation was achieved in awake conditions and imaged under anesthesia. RESULTS: Manganese-enhanced MRI showed three layers, corresponding to the inner retina, outer retina, and the choroid. In normal animals, the outer retina showed higher MEMRI activity in dark compared to light; the inner retina displayed lower activity in dark compared to light; and the choroid showed no difference in activity. Manganese-enhanced MRI activity changed as early as 14 days after hyperglycemia and decreased with duration of hyperglycemia in the outer retina in dark relative to light adaptation. The choroid also had altered MEMRI activity at 14 days, which returned to normal by 30 days. No differences in MEMRI activity were detected in the inner retina. CONCLUSIONS: Manganese-enhanced MRI detects progressive reduction in calcium activity with duration of hyperglycemia in the outer retina as early as 14 days after hyperglycemia, earlier than any other time point reported in the literature.
PURPOSE: To employ high-resolution manganese-enhanced MRI (MEMRI) to study abnormal calcium activity in different cell layers in streptozotocin-induced diabeticrat retinas, and to determine whether MEMRI detects changes at earlier time points than previously reported. METHODS:Sprague-Dawley rats were studied 14 days (n = 8) and 30 days (n = 5) after streptozotocin (STZ) or vehicle (n = 7) injection. Manganese-enhanced MRI at 20 × 20 × 700 μm, in which contrast is based on manganese as a calcium analogue and an MRI contrast agent, was obtained in light and dark adaptation of the retina in the same animals in which one eye was covered and the fellow eye was not. The MEMRI activity encoding of the light and dark adaptation was achieved in awake conditions and imaged under anesthesia. RESULTS:Manganese-enhanced MRI showed three layers, corresponding to the inner retina, outer retina, and the choroid. In normal animals, the outer retina showed higher MEMRI activity in dark compared to light; the inner retina displayed lower activity in dark compared to light; and the choroid showed no difference in activity. Manganese-enhanced MRI activity changed as early as 14 days after hyperglycemia and decreased with duration of hyperglycemia in the outer retina in dark relative to light adaptation. The choroid also had altered MEMRI activity at 14 days, which returned to normal by 30 days. No differences in MEMRI activity were detected in the inner retina. CONCLUSIONS:Manganese-enhanced MRI detects progressive reduction in calcium activity with duration of hyperglycemia in the outer retina as early as 14 days after hyperglycemia, earlier than any other time point reported in the literature.
Authors: L P Aiello; T W Gardner; G L King; G Blankenship; J D Cavallerano; F L Ferris; R Klein Journal: Diabetes Care Date: 1998-01 Impact factor: 19.112
Authors: M A Johnson; G A Lutty; D S McLeod; T Otsuji; R W Flower; G Sandagar; T Alexander; S M Steidl; B C Hansen Journal: Exp Eye Res Date: 2005-01 Impact factor: 3.467
Authors: Bruce A Berkowitz; Bryce X Bredell; Christopher Davis; Marijana Samardzija; Christian Grimm; Robin Roberts Journal: Invest Ophthalmol Vis Sci Date: 2015-12 Impact factor: 4.799